IN8bio (NASDAQ:INAB – Get Free Report) had its target price dropped by HC Wainwright from $8.00 to $6.00 in a research report issued on Friday,Benzinga reports. The firm currently has a “buy” rating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback